therapies < therapy < there

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 55.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000004 (2020)	Mike Becker [Suisse]	[Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
000010 (2020)	Aline Pfefferle [Australie] ; Nicholas D. Huntington [Australie]	You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
000029 (2020)	Sara Benchérifa ; Bouchra Amine ; Imane El Binoune ; Samira Rostom ; Rachid Bahiri	Two cases of perforated corneal ulcers complicating rheumatoid arthritis treated successfully by biological therapy
000032 (2020)	Marc Feldmann [Royaume-Uni] ; Ravinder N. Maini [Royaume-Uni] ; James N. Woody [États-Unis] ; Stephen T. Holgate [Royaume-Uni] ; Gregory Winter [Royaume-Uni] ; Matthew Rowland [Royaume-Uni] ; Duncan Richards [Royaume-Uni] ; Tracy Hussell [Royaume-Uni]	Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
000035 (2020)	Limin Li [République populaire de Chine] ; Jie Liu [République populaire de Chine] ; Mengyuan Xu [République populaire de Chine] ; Hongjuan Yu [République populaire de Chine] ; Chengfang Lv [République populaire de Chine] ; Fenglin Cao [République populaire de Chine] ; Zhenkun Wang [République populaire de Chine] ; Yueyue Fu [République populaire de Chine] ; Mingwen Zhang [République populaire de Chine] ; Hongbin Meng [République populaire de Chine] ; Xiaoqian Zhang [République populaire de Chine] ; Liqing Kang [République populaire de Chine] ; Zhuo Zhang [République populaire de Chine] ; Jinmei Li [République populaire de Chine] ; Jiawei Feng [République populaire de Chine] ; Xin Lian [République populaire de Chine] ; Lei Yu [République populaire de Chine] ; Jin Zhou [République populaire de Chine]	Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients
000065 (2020)	Ian Pirker [Suisse] ; Andrea Rubbert-Roth [Suisse] ; Johannes Von Kempis [Suisse] ; Martin Fehr [Suisse] ; Thomas Neumann [Suisse]	Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy.
000098 (2020)	Seda Colak [Turquie] ; Emre Tekgoz [Turquie] ; Muhammet Cinar [Turquie] ; Sedat Yilmaz [Turquie]	The assessment of tocilizumab therapy on recurrent attacks of patients with familial Mediterranean fever: A retrospective study of 15 patients.
000100 (2020)	Jianan Xu [République populaire de Chine] ; Huijing Ye [République populaire de Chine] ; Guo Chen [République populaire de Chine] ; Jingqiao Chen [République populaire de Chine] ; Rongxin Chen [République populaire de Chine] ; Huasheng Yang [République populaire de Chine]	The Therapeutic Effect of Combination of Orbital Decompression Surgery and Methylprednisolone Pulse Therapy on Patients with Bilateral Dysthyroid Optic Neuropathy
000126 (2020)	E C Schwaneck [Allemagne] ; R. Renner [Allemagne] ; L. Junker [Allemagne] ; H-P Tony [Allemagne] ; S. Kleinert [Allemagne] ; M. Gernert [Allemagne] ; M. Schmalzing [Allemagne] ; O. Gadeholt [Allemagne]	T cells, natural killer cells, and γδT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapy.
000138 (2020)	Hao Zhang ; Yongxian Hu	Successful treatment of T315I BCR-ABL mutated lymphoid blast phase chronic myeloid leukemia with chimeric antigen receptor T cell therapy followed by dasatinib
000151 (2020)	Joanna Wai Yee Leong [Singapour] ; Peter P. Cheung [Singapour] ; Sajeewani Dissanayake [Singapour] ; Warren Weng Seng Fong [Singapour] ; Keng Hong Leong [Singapour] ; Ying Ying Leung [Singapour] ; Anita Yee Nah Lim [Singapour] ; Nai Lee Lui [Singapour] ; Mona Manghani [Singapour] ; Amelia Santosa [Singapour] ; Melonie Kannamma Sriranganathan [Singapour] ; Ernest Suresh [Singapour] ; Teck Choon Tan [Singapour] ; Gim Gee Teng [Singapour] ; Manjari Lahiri [Singapour]	Singapore Chapter of Rheumatologists updated consensus statement on the eligibility for government subsidization of biologic and targeted-synthetic therapy for the treatment of rheumatoid arthritis.
000157 (2020)	Jingsheng Hua [République populaire de Chine] ; Weiqing Qian [République populaire de Chine] ; Xiaoxia Wu [République populaire de Chine] ; Lili Zhou [République populaire de Chine] ; Lei Yu [République populaire de Chine] ; Suning Chen [République populaire de Chine] ; Jian Zhang [République populaire de Chine] ; Huiying Qiu [République populaire de Chine]	Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature
000178 (2020)	Adelaide Sofia Batalha Figueiredo [Portugal] ; Ana Luísa Oliveira [Portugal] ; Ant Nio Caetano [Portugal] ; Maria Francisca Moraes-Fontes [Portugal]	SAPHO: has the time come for tailored therapy?
000197 (2020)	Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie]	Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
000224 (2020)	Jie Ma [République populaire de Chine] ; Peng Xia [République populaire de Chine] ; Yangzhong Zhou [République populaire de Chine] ; Zhengyin Liu [République populaire de Chine] ; Xiang Zhou [République populaire de Chine] ; Jinglan Wang [République populaire de Chine] ; Taisheng Li [République populaire de Chine] ; Xiaowei Yan [République populaire de Chine] ; Limeng Chen [République populaire de Chine] ; Shuyang Zhang [République populaire de Chine] ; Yan Qin [République populaire de Chine] ; Xuemei Li [République populaire de Chine]	Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19
000254 (2020)	Yan Guo [République populaire de Chine] ; Hai Li [République populaire de Chine] ; Xueying Chen [République populaire de Chine] ; Huasheng Yang [République populaire de Chine] ; Hongyu Guan [République populaire de Chine] ; Xiaoying He [République populaire de Chine] ; Yuxin Chen [République populaire de Chine] ; Sunil Pokharel [République populaire de Chine] ; Haipeng Xiao [République populaire de Chine] ; Yanbing Li [République populaire de Chine]	Novel Roles of Chloroquine and Hydroxychloroquine in Graves’ Orbitopathy Therapy by Targeting Orbital Fibroblasts
000260 (2020)	Ruksana Huda	New Approaches to Targeting B Cells for Myasthenia Gravis Therapy
000278 (2020)	Dimitrios A. Pappas [États-Unis] ; Taylor Blachley [États-Unis] ; Steve Zlotnick [États-Unis] ; Jennie Best [États-Unis] ; Kelechi Emeanuru [États-Unis] ; Joel M. Kremer [États-Unis]	Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry.
000289 (2020)	Ibrahim Yakoub-Agha [France] ; Christian Chabannon [France] ; Peter Bader [Allemagne] ; Grzegorz W. Basak [Pologne] ; Halvard Bonig [Allemagne] ; Fabio Ciceri [Italie] ; Selim Corbacioglu [Allemagne] ; Rafael F. Duarte [Espagne] ; Hermann Einsele [Allemagne] ; Michael Hudecek [Allemagne] ; Marie José Kersten [Pays-Bas] ; Ulrike Köhl [Allemagne] ; Jürgen Kuball [Pays-Bas] ; Stephan Mielke [Suède] ; Mohamad Mohty [France] ; John Murray [Royaume-Uni] ; Arnon Nagler [Israël] ; Stephen Robinson [Royaume-Uni] ; Riccardo Saccardi [Italie] ; Fermin Sanchez-Guijo [Espagne] ; John A. Snowden [Royaume-Uni] ; Micha Srour [France] ; Jan Styczynski [Pologne] ; Alvaro Urbano-Ispizua [Espagne] ; Patrick J. Hayden [Irlande (pays)] ; Nicolaus Kröger [Allemagne]	Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
000311 (2020)	Durga Prasanna Misra [Inde] ; Sakir Ahmed [Inde] ; Vikas Agarwal [Inde]	Is biological therapy in systemic sclerosis the answer?
000316 (2020)	Yuki Saito [Japon] ; Shujiro Hayashi [Japon] ; Takashi Gonmori [Japon] ; Yoichiro Hamasaki [Japon] ; Ken Igawa [Japon]	Interrupting tocilizumab therapy-induced psoriasis-like eruption in a patient with rheumatoid arthritis and Crohn's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "therapy" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "therapy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    therapy
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021